Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2018-04-17 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
GLOBAL BIOENERGIES PRESS RELEASE
Regulatory Filings Classification · 85% confidence The document is a press release dated April 17th, 2018, announcing a collaboration between Global Bioenergies and SkyNRG regarding the ASTM-certification process for sustainable aviation fuel (SAF) derived from bio-isobutene. It details the technical steps (Tier 1 testing) and strategic goals (commercialization and decarbonization). This type of announcement, focusing on a specific business development, partnership, or technical milestone, does not fit the definitions for formal regulatory filings (10-K, IR, ER, AR) or shareholder communications (DEF 14A, DVA). It is a general corporate announcement. Since there is no specific category for 'Press Release' or 'Partnership Announcement', and it is not a report itself, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate announcements that don't fit elsewhere, although 'LTR' (Legal Proceedings Report) or 'CAP' (Capital/Financing Update) are also possibilities if the collaboration involved significant financial commitment, but based purely on the text describing a technical/commercial partnership, RNS is the best fit among the provided options for a non-standard announcement.
2018-04-17 English
GLOBAL BIOENERGIES COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 95% confidence The document is a press release dated April 5, 2018, announcing a significant operational milestone: the first road testing phase of renewable gasoline (over 34% renewable isobutene derivatives) in an Audi vehicle, along with preliminary engine test results from FEV. It details the technology, the partnership with Audi, and the next steps towards commercial deployment. This type of announcement, focusing on operational progress, testing results, and strategic partnerships, is characteristic of an Earnings Release (ER) if it were summarizing period results, or more generally, a significant corporate update. Since it is not a formal regulatory filing (like 10-K or IR), nor a transcript (CT), nor a management discussion (MDA), nor a specific financing/dividend notice, it fits best as an initial announcement of operational/technical progress, which often aligns with the scope of an Earnings Release (ER) or a general Regulatory Filing (RNS). Given the focus on announcing key achievements and results (even if technical/operational rather than purely financial period results), ER is a strong candidate, but since it's a general press release about a technical achievement and partnership, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for non-standard, material news that isn't explicitly covered by other codes like DIV, CAP, or MANG. However, in many databases, significant operational updates that are not mandatory SEC filings are often categorized as ER if they relate to the core business performance drivers, or RNS if they are general news. Given the structure and content (announcing a major step forward and presenting results), it functions as a high-level announcement. I will classify it as RNS as it is a general press release announcing a major development, which is the broadest category for material, non-standard news.
2018-04-05 French
GLOBAL BIOENERGIES PRESS RELEASE
Regulatory Filings Classification · 90% confidence The document is a press release dated April 5, 2018, announcing a milestone: the first use of gasoline containing over 34% renewable compounds (derived from isobutene) to fuel an Audi car on a circuit, along with the presentation of engine testing results from FEV. This is a general corporate update highlighting a technological achievement and partnership progress, rather than a formal regulatory filing (like 10-K, AR, or IR) or a specific financial event announcement (like DIV, CAP, or ER). Since it details a significant operational/strategic development and is presented as a news item, it best fits the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, although 'Investor Presentation' (IP) or 'Management Reports' (MDA) could be considered if it were more focused on investor strategy. Given the format and content (a press release about a technical/commercial step), RNS is the most appropriate fallback for non-standard announcements.
2018-04-05 English
GLOBAL BIOENERGIES COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 85% confidence The document is a short press release dated March 22, 2018, announcing that Global Bioenergies will present engine test results with its renewable fuels on April 5th, in partnership with Audi and FEV. It contains company background information and contact details. It is not a full financial report (like 10-K or IR), an earnings release (ER), or a formal regulatory filing. Since it is an announcement about presenting specific technical/business results, and it doesn't fit the definitions for AGM-R, ER, CT, or IP, it is best classified as a general Regulatory Filing (RNS) or potentially a specialized announcement. Given the context of presenting test results, it is a specific business update, but RNS serves as the best fit among the provided options for a non-standard, non-financial results announcement that is not a standard presentation (IP) or earnings release (ER). However, since it is an announcement about a future presentation of technical results, it is a specific type of corporate communication. Given the short length and announcement nature, RNS is the most appropriate fallback, although it is not a typical regulatory filing. It is not a DIV, DIRS, or MANG announcement. It is not a formal Investor Presentation (IP) as it is a press release announcing the presentation, not the presentation itself. Therefore, RNS is the most suitable general category.
2018-03-22 French
GLOBAL BIOENERGIES PRESS RELEASE
Report Publication Announcement Classification · 99% confidence The document is a short press release dated March 22nd, 2018, announcing that Global Bioenergies will present engine testing results on April 5th, joined by its partners Audi and FEV. It is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a formal dividend notice (DIV). It is an announcement about an upcoming presentation or event where results will be shared. This fits best under the category of general regulatory/investor news that doesn't fit a more specific financial filing type. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate announcement/news release that is not a specific financial report or management change, although 'Investor Presentation' (IP) might seem close, this is an announcement *about* a presentation, not the presentation itself. However, since it is an announcement of an event where results will be presented, and it is very short, it functions as a general corporate update. RNS is the best fit as a general regulatory announcement/news release.
2018-03-22 English
GLOBAL BIOENERGIES - COMMUNIQUE DE PRESSE
Environmental & Social Information Classification · 99% confidence The document is a press release dated March 8, 2018, announcing a key milestone achieved in a partnership between Global Bioenergies and Audi regarding the production and shipment of renewable fuels (isobutene derivatives). It details technical progress, quotes management, and provides company background. This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR), best fits the general category for corporate news and updates that don't fit elsewhere. Since it is a general corporate announcement about a partnership milestone and product development, and not a specific financial report, dividend notice, or management change, the most appropriate classification among the provided options is 'Regulatory Filings' (RNS) as a general regulatory/corporate announcement fallback, although 'LTR' (Legal Proceedings Report) or 'CAP' (Capital/Financing Update) are less fitting. Given the context of a press release detailing operational progress, RNS serves as the best general corporate announcement category when specific categories like ER or MANG do not apply.
2018-03-09 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.